Valve Heart Disease
41
10
10
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
1 terminated out of 41 trials
94.4%
+7.9% vs benchmark
5%
2 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 17 completed trials
Clinical Trials (41)
Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery
Effects of Myofascial Release on Cardiac Patients After Median Sternotomy
Post-Operative Myocardial Incident & Atrial Fibrillation
Comparative Imaging Assessment of Valvular Heart Disease
Impact of a Corrie Cardiac Rehabilitation Program
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material
FRAILTY Classification Algorithm for the Corsano CARDIOWATCH 287-2: a Development and Validation Study
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve Versus Mechanical Valve
Allogeneic Valve Transplantation
Freestyle-Perimount Calcification Comparison
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
SATURN Transcatheter Mitral Valve Replacement for Functional Mitral Regurgitation
PREhabilitation in Patients Awaiting Acute Inpatient Cardiac SurgEry
Transfusion in Cardiac Valve Surgery
Computational Assessment of Bioprosthetic Aortic Valve Function
Efficacy and Safety of the Sync-AV II Temporary Cardiac Pacing Catheter
RecoveryPlus Telerehab Platform Pilot Study